PRL and schizophrenia: In our study, the conventional metformin dose (1–2 g/day) used to treat diabetes mellitus in schizophrenia with co-morbid T2DM also had the same function of lowering PRL levels and showed a negative dose-dependence of metformin dose and PRL levels.